Bio-Techne: Q3 Earnings Insights

Bio-Techne (NASDAQ:TECH) reported its Q3 earnings results on Wednesday, May 3, 2023 at 06:30 AM. Here’s what investors…

Bio-Techne (NASDAQ:TECH) reported its Q3 earnings results on Wednesday, May 3, 2023 at 06:30 AM.

Here’s what investors need to know about the announcement.

Earnings

Bio-Techne reported in-line EPS of $0.53 versus an estimate of $0.53.

Revenue was up $3.77 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.15 which was followed by a 2.09% drop in the share price the next day.

Here’s a look at Bio-Techne’s past performance:

Quarter Q2 2023 Q1 2023 Q4 2022 Q3 2022
EPS Estimate 0.62 0.46 0.52 0.50
EPS Actual 0.47 0.45 0.51 0.54
Revenue Estimate 288.79M 282.62M 287.12M 279.92M
Revenue Actual 271.58M 269.65M 288.23M 290.38M

To track all earnings releases for Bio-Techne visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Q2 Earnings Season: Energy Companies Likely To Cushion Downside; Here Are The Leading And Lagging Sectors

The second-quarter reporting season is upon us, and the second quarter has been a tricky one for companies to navigate. COVID lockdowns in China – a nation often called the "world's factory," the war in Ukraine and skyrocketing inflation served as recipes for a looming disaster.

SPY

Read More

Disney’s Bob Iger Confident In Landing Long-Term NBA Rights Deal As Media Giant Enhances Streaming With ESPN Tile And Shifts Marvel Strategy

The Walt Disney Company is making major moves to enhance its streaming offerings and superhero content strategy, while expressing confidence in securing long-term NBA rights, according to remarks from the CEO on the company's second-quarter 2024 earnings call.

CMCSA